U.S., Dec. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07297160) titled 'CD70.CAR for CD70+ Lymphoma, Myeloma and Solid Tumors' on Dec. 09.
Brief Summary: This study is for patients who have a type of cancer that expresses the protein CD70, which includes lymphoma (lymph gland cancer), myeloma and solid tumors including some sarcomas and kidney cancers, and the cancer has come back or has not gone away after standard of care treatment.
As there are limited or no remaining standard treatments available to treat this cancer, patients are being asked to volunteer to be in a gene transfer research study using special immune cells to create a specialized immune cell that will recognize a protein called CD70 ...